{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:51:35Z","timestamp":1781646695502,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mittal Fund Cleveland Clinic Philanthropy"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["award MR\/Y000404\/1"],"award-info":[{"award-number":["award MR\/Y000404\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SRLF \u2013 101 Endowment Fund Christophe Vinsonneau"},{"name":"Institute Servier research fellowship grant, Ramsay G\u00e9n\u00e9rale de Sant\u00e9 mobility grant"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR303768"],"award-info":[{"award-number":["NIHR303768"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Corticosteroids are now recommended in guidelines for patients with acute respiratory distress syndrome (ARDS); however, optimal timing and dose remain uncertain. We assessed whether the association between corticosteroids and hospital mortality varies over time in the ICU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective observational study of ARDS patients identified in the MIMIC-IV database (2008\u20132019). To analyze the time-varying association between corticosteroids and hospital mortality, we constructed overlapping three-day windows from ARDS days 0 to 14. We compared windows with no corticosteroid exposure (0\u00a0mg) to windows meeting cumulative prednisolone-equivalent dose thresholds chosen to approximate regimens from landmark clinical trials (\u2265\u200930, \u2265\u2009150, \u2265270, \u2265\u2009390\u00a0mg PE over 3 days). We estimated overlap-weighted, doubly robust adjusted risk differences (OWRD) for hospital mortality using augmented inverse probability weighting (AIPW).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 987 included patients, 354 (35.9%) received corticosteroids, with 262 (74.1%) and 128 (36.2%) of treated patients meeting the \u2265\u2009150\u00a0mg and \u2265\u2009390\u00a0mg thresholds in at least one window. Early, low cumulative dosing (\u2265\u200930\u00a0mg\/3d) was not associated with a detectable difference in hospital mortality (e.g., days 0\u20132: OWRD 0.03, 95% CI\u2009\u2212\u20090.05 to 0.10). Conversely, higher cumulative doses received later in the ICU stay (\u2265\u2009150\u2013390\u00a0mg\/3d after day 8) were associated with higher observed mortality (e.g., days 8\u201310: OWRD 0.25, 95% CI 0.11\u20130.39). However, estimates in late, high-dose windows were less precise due to limited covariate overlap and smaller sample sizes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In unselected ARDS, we found no evidence of benefit or harm from early lower-dose corticosteroids, but higher cumulative doses later in ICU stay were associated with higher mortality, possibly reflecting residual confounding and limited covariate overlap. These hypothesis generating findings support randomized studies testing corticosteroid timing and dose in ARDS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-026-04251-w","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:18:06Z","timestamp":1774487886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time-varying associations between corticosteroid dose and hospital mortality in ARDS: a sliding-window analysis of MIMIC-IV"],"prefix":"10.1186","volume":"26","author":[{"given":"Dominic C.","family":"Marshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Jamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Antcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Parbhoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"8","key":"4251_CR1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788\u2013800. https:\/\/doi.org\/10.1001\/jama.2016.0291.","journal-title":"JAMA"},{"key":"4251_CR2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","volume":"400","author":"LDJ Bos","year":"2022","unstructured":"Bos LDJ, Ware LB. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet. 2022;400:1145\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(22)01485-4.","journal-title":"Lancet"},{"issue":"2","key":"4251_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1183\/09031936.06.00125404","volume":"27","author":"PJ Barnes","year":"2006","unstructured":"Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J. 2006;27(2):413\u201326. https:\/\/doi.org\/10.1183\/09031936.06.00125404.","journal-title":"Eur Respir J"},{"issue":"12 Pt 2","key":"4251_CR4","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1016\/j.lpm.2011.04.023","volume":"40","author":"GU Meduri","year":"2011","unstructured":"Meduri GU, Bell W, Sinclair S, Annane D. Pathophysiology of acute respiratory distress syndrome: glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment. Presse Med. 2011;40(12 Pt 2):e543\u201360. https:\/\/doi.org\/10.1016\/j.lpm.2011.04.023.","journal-title":"Presse Med"},{"issue":"1","key":"4251_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202311-2011ST","volume":"209","author":"N Qadir","year":"2024","unstructured":"Qadir N, Sahetya S, Munshi L, et al. An update on management of adult patients with acute respiratory distress syndrome: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2024;209(1):24\u201336. https:\/\/doi.org\/10.1164\/rccm.202311-2011ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4251_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.chest.2020.07.059","volume":"159","author":"MK Hensley","year":"2021","unstructured":"Hensley MK, Sjoding MW, Prescott HC. COUNTERPOINT: Should corticosteroids be routine treatment in early ARDS? No. Chest. 2021;159(1):29\u201333. https:\/\/doi.org\/10.1016\/j.chest.2020.07.059.","journal-title":"Chest"},{"issue":"16","key":"4251_CR7","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa051693","volume":"354","author":"KP Steinberg","year":"2006","unstructured":"Steinberg KP, Hudson LD, Goodman RB, National Heart, Lung, and Blood Institute ARDS Clinical Trials Network, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671\u201384. https:\/\/doi.org\/10.1056\/NEJMoa051693.","journal-title":"N Engl J Med"},{"key":"4251_CR8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1541-0420.2005.00377.x","volume":"61","author":"H Bang","year":"2005","unstructured":"Bang H, Robins JM. Doubly robust estimation in missing data and causal inference models. Biometrics. 2005;61:962\u201373.","journal-title":"Biometrics"},{"issue":"8","key":"4251_CR9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jclinepi.2009.11.020","volume":"63","author":"D Westreich","year":"2010","unstructured":"Westreich D, Lessler J, Funk MJ. Propensity score estimation: machine learning and classification methods as alternatives to logistic regression. J Clin Epidemiol. 2010;63(8):826\u201333. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.11.020.","journal-title":"J Clin Epidemiol"},{"key":"4251_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/sim.3782","volume":"29","author":"BK Lee","year":"2010","unstructured":"Lee BK, Lessler J, Stuart EA. Improving propensity score weighting using machine learning. Stat Med. 2010;29:337\u201346. https:\/\/doi.org\/10.1002\/sim.3782.","journal-title":"Stat Med"},{"issue":"1","key":"4251_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson AEW, Bulgarelli L, Shen L, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10(1):1. https:\/\/doi.org\/10.1038\/s41597-022-01899-x.","journal-title":"Sci Data"},{"key":"4251_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13613-021-00951-0","volume":"11","author":"G Moreno","year":"2021","unstructured":"Moreno G, Carbonell R, Martin-Loeches I, et al. Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study. Ann Intensive Care. 2021;11:159. https:\/\/doi.org\/10.1186\/s13613-021-00951-0.","journal-title":"Ann Intensive Care"},{"key":"4251_CR13","unstructured":"National Institute for Health and Care Excellence (NICE). Equivalent anti-inflammatory doses of oral corticosteroids. NICE Clinical Knowledge Summaries (CKS). 2024. (Accessed 27 Jan 2026)."},{"issue":"21","key":"4251_CR14","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"P-F Dequin","year":"2023","unstructured":"Dequin P-F, Meziani F, Quenot J-P, et al. Hydrocortisone in severe community-acquired pneumonia. N Engl J Med. 2023;388(21):1931\u201341. https:\/\/doi.org\/10.1056\/NEJMoa2215145.","journal-title":"N Engl J Med"},{"issue":"3","key":"4251_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar J, Ferrando C, Mart\u00ednez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267\u201376. https:\/\/doi.org\/10.1016\/S2213-2600(19)30417-5.","journal-title":"Lancet Respir Med"},{"key":"4251_CR16","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00134-017-4914-x","volume":"43","author":"D Annane","year":"2017","unstructured":"Annane D, Pastores SM, Arlt W, et al. Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a multispecialty task force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM). Intensive Care Med. 2017;43:1781\u201392.","journal-title":"Intensive Care Med"},{"issue":"2","key":"4251_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/jama.280.2.159","volume":"280","author":"GU Meduri","year":"1998","unstructured":"Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280(2):159\u201365. https:\/\/doi.org\/10.1001\/jama.280.2.159.","journal-title":"JAMA"},{"issue":"2","key":"4251_CR18","doi-asserted-by":"publisher","first-page":"R63","DOI":"10.1186\/cc13819","volume":"18","author":"S-Y Ruan","year":"2014","unstructured":"Ruan S-Y, Lin H-H, Huang C-T, et al. Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care. 2014;18(2):R63. https:\/\/doi.org\/10.1186\/cc13819.","journal-title":"Crit Care"},{"issue":"5","key":"4251_CR19","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00134-015-4095-4","volume":"42","author":"GU Meduri","year":"2016","unstructured":"Meduri GU, Bridges L, Shih M-C, et al. Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients\u2019 data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med. 2016;42(5):829\u201340. https:\/\/doi.org\/10.1007\/s00134-015-4095-4.","journal-title":"Intensive Care Med"},{"key":"4251_CR20","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1038\/s41467-025-59643-z","volume":"16","author":"S Rajendran","year":"2025","unstructured":"Rajendran S, Xu Z, Pan W, et al. Multicenter target trial emulation to evaluate corticosteroids for sepsis stratified by predicted organ dysfunction trajectory. Nat Commun. 2025;16:4450. https:\/\/doi.org\/10.1038\/s41467-025-59643-z.","journal-title":"Nat Commun"},{"key":"4251_CR21","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.chest.2021.07.009","volume":"160","author":"YA Khan","year":"2021","unstructured":"Khan YA, Fan E, Ferguson ND. Precision medicine and heterogeneity of treatment effect in therapies for ARDS. Chest. 2021;160:1729\u201338.","journal-title":"Chest"},{"key":"4251_CR22","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1164\/rccm.202105-1302OC","volume":"204","author":"P Sinha","year":"2021","unstructured":"Sinha P, Furfaro D, Cummings MJ, et al. Latent class analysis reveals COVID-19-related acute respiratory distress syndrome subgroups with differential responses to corticosteroids. Am J Respir Crit Care Med. 2021;204:1274\u201385. https:\/\/doi.org\/10.1164\/rccm.202105-1302OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"4251_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.202406-1241OC","volume":"211","author":"RBE van Amstel","year":"2025","unstructured":"van Amstel RBE, Bartek B, Vlaar APJ, et al. Temporal transitions of the hyperinflammatory and hypoinflammatory phenotypes in critical illness. Am J Respir Crit Care Med. 2025;211:347\u201356.","journal-title":"Am J Respir Crit Care Med"},{"key":"4251_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-08089-4","author":"J Pensier","year":"2025","unstructured":"Pensier J, Fosset M, Paschold BS, et al. Temporal stability of phenotypes of acute respiratory distress syndrome: clinical implications for early corticosteroid therapy and mortality. Intensive Care Med. 2025. https:\/\/doi.org\/10.1007\/s00134-025-08089-4.","journal-title":"Intensive Care Med"},{"key":"4251_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13054-022-04097-8","volume":"26","author":"P Lamouche-Wilquin","year":"2022","unstructured":"Lamouche-Wilquin P, Souchard J, Pere M, et al. Early steroids and ventilator-associated pneumonia in COVID-19-related ARDS. Crit Care. 2022;26:233. https:\/\/doi.org\/10.1186\/s13054-022-04097-8.","journal-title":"Crit Care"},{"issue":"1","key":"4251_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3904\/kjim.2019.153","volume":"36","author":"MS Baek","year":"2021","unstructured":"Baek MS, Lee Y, Hong S-B, et al. Effect of corticosteroid therapy in the early phase of acute respiratory distress syndrome: a propensity-matched cohort study. Korean J Intern Med. 2021;36(1):145\u201353. https:\/\/doi.org\/10.3904\/kjim.2019.153.","journal-title":"Korean J Intern Med"},{"key":"4251_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13613-020-0642-4","volume":"10","author":"M-J Tsai","year":"2020","unstructured":"Tsai M-J, Yang K-Y, Chan M-C, et al. Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study. Ann Intensive Care. 2020;10:26. https:\/\/doi.org\/10.1186\/s13613-020-0642-4.","journal-title":"Ann Intensive Care"},{"key":"4251_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13054-017-1723-0","volume":"21","author":"M Takaki","year":"2017","unstructured":"Takaki M, Ichikado K, Kawamura K, et al. The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study. Crit Care. 2017;21:135. https:\/\/doi.org\/10.1186\/s13054-017-1723-0.","journal-title":"Crit Care"},{"issue":"1","key":"4251_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12931-022-02186-4","volume":"23","author":"X Chang","year":"2022","unstructured":"Chang X, Li S, Fu Y, et al. Safety and efficacy of corticosteroids in ARDS patients: a systematic review and meta-analysis of RCT data. Respir Res. 2022;23(1):301. https:\/\/doi.org\/10.1186\/s12931-022-02186-4.","journal-title":"Respir Res"},{"key":"4251_CR30","doi-asserted-by":"publisher","first-page":"2381086","DOI":"10.1080\/07853890.2024.2381086","volume":"56","author":"G Li","year":"2024","unstructured":"Li G, Chen D, Gao F, et al. Efficacy of corticosteroids in patients with acute respiratory distress syndrome: a meta-analysis. Ann Med. 2024;56:2381086. https:\/\/doi.org\/10.1080\/07853890.2024.2381086.","journal-title":"Ann Med"},{"issue":"25","key":"4251_CR31","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1056\/NEJM198712173172504","volume":"317","author":"GR Bernard","year":"1987","unstructured":"Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317(25):1565\u201370. https:\/\/doi.org\/10.1056\/NEJM198712173172504.","journal-title":"N Engl J Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04251-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04251-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04251-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:52:38Z","timestamp":1781643158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04251-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4251"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04251-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The MIMIC-IV database has received ethical approval from the institutional review boards (IRB) at BIDMC and MIT, and, because the database does not contain protected health information, a waiver of the requirement for informed consent was included in the IRB approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The MIMIC-IV database has been fully deidentified and has a waiver for informed consent therefore individual level patient consent is not required. Further details are available at\n                      \n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"209"}}